The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma

BACKGROUND: Insulin/insulin-like growth factor-1 signalling may underlie the promoting effect of type 2 diabetes on cancer. This study examined the association of diabetes, including steroid-induced diabetes (SID), and the impact of anti-diabetic medication on clinical outcomes of multiple myeloma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, W, Merriman, K, Nabaah, A, Seval, N, Seval, D, Lin, H, Wang, M, Qazilbash, M H, Baladandayuthapani, V, Berry, D, Orlowski, R Z, Lee, M-H, Yeung, S-C J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119980/
https://www.ncbi.nlm.nih.gov/pubmed/24921909
http://dx.doi.org/10.1038/bjc.2014.307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119980/
https://www.ncbi.nlm.nih.gov/pubmed/24921909
http://dx.doi.org/10.1038/bjc.2014.307

Ejemplares similares